Breast

• breast pathology
  20 January 2012

  mammary pathology
  Web sites
  http://www.breastpathology.info/

• mammary MALT lymphoma
  6 December 2011

  Mammary marginal zone B-cell lymphoma

• mammary diffuse large B-cell lymphoma
  6 December 2011

  Mammary diffuse large B cell lymphoma, Mammary DLBCL)

• sentinel lymph node for mammary carcinoma
  28 November 2011

  sentinel lymph nodes for breast cancer; mammary carcinoma metastasis in axilary lymph node
  Node stage Criteria pN(mol+) Tumor cells detected by molecular methods only. pN0(i+) Isolated tumor cells < 0.2 mm or < 200 cells pN1mi Tumor cells >= 0.2 mm and < 2 mm pN1a 1 - 3 lymph nodes,at least one focus >= 2mm.
  IHC
  Cytokeratin 19 (CK19 or KRT19) messenger RNA amplification
  Sentinel node (SN) pathologic analysis shows great limitations related to (...)

• mammary invasive lobular carcinoma
  9 February 2011

  breast invasive lobular carcinoma; invasive lobular carcinoma of the breast; mammary infiltrating lobular carcinoma; lobular carcinoma of the breast: mammary invasive lobular carcinoma; infiltrating lobular carcinoma of the breast PO WPA
  Definition: Invasive lobular carcinoma shows single file infiltrative neoplastic cells, which are negative for E-cadherin and shows cytoplasmic p120 cadherin as opposed to surface p120.
  The lesion usually presents as a palpable mass, and mammography (...)

• mammary intracystic papillary carcinoma
  22 November 2010

  Intracystic Papillary Carcinoma of the Breast

• mammary invasive ductal carcinoma
  18 November 2010

  Invasive ductal carcinomas of the breast; mammary invasive ductal carcinoma; mammary infiltrative ductal carcinoma; mammary infiltrating ductal carcinoma; IDC
  Definition: Invasive ductal carcinoma has malignant infiltrating glands with a desmoplastic stroma, and is negative for myoepithelial cell markers, such as p63 and SMA. It is graded by the Nottingham grading system, which depends on tubule formation, nuclear pleomorphism, and mitotic count.
  Links (...)

• ERBB2-associated mammary carcinoma
  11 October 2010

  HER2 positive mammary carcinoma; HER2 positive breast cancer
  One-third of patients with breast cancer overexpress the ERBB2 receptor tyrosine kinase, which is associated not only with a more aggressive phenotype but also reduced responsiveness to hormonal therapies. (#16883574#)
  Around 20% of breast cancers (BC) show ERBB2 gene amplification and overexpression of the ERBB2 tyrosine kinase receptor. They are associated with a poor prognosis but can benefit from targeted therapy.
  ER+ and (...)

• granulomatous mastitis
  21 July 2010

  Etiology
  In a case of granulomatous mastitis due to Corynebacterium kroppenstedtii, a strongly impaired neutrophil responses to Nod2 agonist and a single nucleotide polymorphism within the NOD2 gene (SNP13 [Leu1007fsinsC]) in a heterozygous state have been found. These findings provided a demonstration of impaired Nod2 function associated with corynebacterial infection. (#19641059#)
  References
  First description of NOD2 variant associated with defective neutrophil responses in a woman (...)

• mammary granular cell tumor
  21 June 2010

  Granular cell tumour of the breast; Granular cell tumor of the breast

0 | ... | 200 | 210 | 220 | 230 | 240 | 250 | 260 | 270 | 280 | ... | 330